An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the Spanish National Research Council, has developed a new technique that will accelerate the design of drugs that target ion channels, a type of cell membrane protein involved in numerous diseases, ranging from psychiatric disorders to various types of cancer.

The research, carried out in collaboration with the University of East Anglia and the Qadram Institute (both in the United Kingdom), has been published in the Journal of the American Chemical Society.

Ion channels are cell membrane proteins that regulate the passage of ions into the cell. They are essential in processes as diverse as nerve transmission, muscle contraction and immune response and their dysfunction is associated with numerous disorders, making them therapeutic targets of great interest.